FILE:HUM/HUM-8K-20070227184148.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
 
 
 
      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
          Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
o
o
o
 
Item 5.02(e)  Departure of Directors or Certain Officers; Election of Directors; Appointment of                       Certain Officers; Compensatory Arrangements of Certain Officers
                   At the February 22, 2007 meeting of the Company's Organization & Compensation Committee, a discretionary award was approved for Jonathan T. Lord, M.D., Senior Vice President & Chief Innovation Officer, in the amount of $24,250.
 
 
               Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated:    February 27, 2007


